41
Vaccine for Prevention of Bird Flu
Condition(s): Influenza, Human Last Updated: January 15, 2011Completed
64 Clinical Trials for: Recombinant Cell Bioassay, Page 3 of 4
Hide Studies Not Seeking New Volunteers
42
Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma
Condition(s): Lymphoma Last Updated: April 18, 2009Active, not recruiting
43
Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7
Condition(s): Influenza A Last Updated: February 12, 2013Completed
44
Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults
Condition(s): HIV Infections Last Updated: December 5, 2012Completed
45
Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults
Condition(s): HIV Infections Last Updated: September 24, 2012Completed
46
Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally
Condition(s): Influenza A Virus, H5N1 Subtype; Influenza A Virus; Influenzavirus A; Orthomyxovirdae; H5N1 Virus Last Updated: April 16, 2009Completed
47
Pre Operative Trastuzumab in Operable Breast Cancer
Condition(s): Carcinoma Breast Stage I; HER2 Positive Breast Cancer Last Updated: April 5, 2013Not yet recruiting
48
VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactivat...
Condition(s): Influenza, Human Last Updated: June 22, 2010Completed
49
Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)
Condition(s): HIV Infections Last Updated: February 12, 2010Completed
50
Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults
Condition(s): HIV Infections Last Updated: November 7, 2012Completed
51
Safety of and Immune Response to the Experimental Preventive HIV Vaccine, EP HIV-1090, in Healthy, HIV-1 Uninfected Adults
Condition(s): HIV Infections Last Updated: April 8, 2013Completed
52
Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive Adults
Condition(s): Malaria Last Updated: January 14, 2013Completed
53
To Identify HLA-A1101-restricted Peptide Epitopes Derived From Novel Oncoantigens (URLC10, KIF20A, and CDCA1) Applicable for Cancer Vaccine in Singapore
Condition(s): Anonymous Donors at Blood Donation Center (NUH) Last Updated: April 3, 2012Recruiting
54
EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-immune Adults
Condition(s): Plasmodium Falciparum Malaria Last Updated: March 28, 2013Completed
55
A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Aplastic Anemia Patients With Immunosuppressive-Therapy Refractory Thrombocytopenia
Condition(s): Anemia, Aplastic; Anemia, Hypoplastic; Thrombocytopenia Last Updated: May 1, 2013Recruiting
56
Safety Study of Avian Flu Vaccine
Condition(s): Influenza A Virus, H5N1 Subtype; Influenza A Virus; Influenzavirus A; Orthomyxoviridae; H5N1 Virus Last Updated: August 29, 2008Completed
57
An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...
Condition(s): Influenza A Virus, H5N1 Subtype Last Updated: December 14, 2011Completed
58
A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers
Condition(s): HIV Infections Last Updated: June 9, 2011Completed
59
Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults
Condition(s): HIV Infections Last Updated: November 28, 2011Active, not recruiting
60
Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison to BCG in Healthy Volunteers in South Africa
Condition(s): Tuberculosis Last Updated: November 18, 2011Completed
